Skip to content
Screener

Vericel VCEL Operating Cash Flow

Operating Cash Flow at other companies

Stryker logo
StrykerSYK
$1.26B+13.5%
CONMED logo
CONMEDCNMD
$37.1M+27.3%
Anika Therapeutics logo
Anika TherapeuticsANIK
-$684K-262%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$447.8M+18.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$15.97M-21.3%
MiMedx Group logo
MiMedx GroupMDXG
-$10.02M-169%

Other financials

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation

See full
Market cap$2.31B+29.1%
Enterprise value$2.28B+25.9%
P/E95.3×-156×
P/S7.5×+0.4×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Vericel’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 8:49 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050836
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accrued expenses(1,588)(2,698)
Operating lease liabilities(3,716)914
Other non-current assets and liabilities, net62797
Net cash provided by operating activities32,57414,814
Investing activities:
Purchases of investments(29,043)(28,975)
Sales and maturities of investments25,21127,150
Expenditures for property and equipment(3,189)(22,345)

Item 1. Financial Statements (Unaudited)

FAQ

What is Vericel's operating cash flow?
Vericel (VCEL) reported operating cash flow of $16.19M in Q2 2026.
How has Vericel's operating cash flow changed year-over-year?
Vericel's operating cash flow increased by 97.1% year-over-year, from $8.21M to $16.19M.
What is the long-term trend for Vericel's operating cash flow?
Over 4 years (2021 to 2025), Vericel's operating cash flow has grown at a 15.6% compound annual growth rate (CAGR), from $29.04M to $51.91M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Vericel's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude